Leading Sponsor in China to Deliver Innovative Therapies to Patients Worldwide with Medidata Cloud News summary: Hengrui adds Medidata Rave EDC, RTSM, Coder, Safety Gateway and Edge CTMS to support emerging market strategy Medidata Cloud enables unified data management for global clinical trial
SHYFT’s leading platform to become PAREXEL’s foundation for outcomes analysis in support of clinical development and commercialization WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 8, 2018-- SHYFT Analytics, a Medidata Solutions (NASDAQ:MDSO) company, and PAREXEL International , a leading innovator of
French biopharmaceutical company aims to improve data access, quality, and workflow efficiencies Expansion agreement builds upon success in use of Rave EDC Company developing therapies for rare forms of cancer and orphan diseases NEW YORK --(BUSINESS WIRE)--Nov.
News Summary Eight winners were recognized for their innovative approaches to addressing key issues in the digital transformation of life science Two-day hackathon also conducted, aimed at improving patient diversity in clinical trials Awards conclude Medidata NEXT NYC, attended by over 1,000 life
CRO accelerates the delivery of life-changing therapies with a single view of data for all clinical trial stakeholders Pharm-Olam unifies operational systems supporting study execution Global CRO optimizes clinical trial outcomes with Medidata’s artificial intelligence and machine learning Customer
Company expands CSR pledges, including participation in the UN Global Compact and the CEO Action on Diversity, and outlines new program goals for the next five years News Summary Medidata commits to the United Nations Global Compact, the CEO Action on Diversity, the Gender Parity Collaborative with
Over 1,000 industry leaders to discuss best practices and the hottest topics in the digital transformation of life sciences News Summary The two-day program features keynotes from global sponsors and CROs and over 50 breakout sessions Over 1,000 attendees to share best practices and connect with
Appointment is initial step toward company pledge to 2020 Women on Boards initiative NEW YORK --(BUSINESS WIRE)--Oct. 22, 2018-- Medidata (NASDAQ: MDSO) announced today that it has appointed Dr. Maria Rivas to its Board of Directors. An endocrinologist with extensive experience as a senior leader
NEW YORK --(BUSINESS WIRE)--Oct. 18, 2018-- Medidata (NASDAQ:MDSO) today announced its financial results for the third quarter of 2018. “Our strong financial and operational performance this quarter highlight the momentum and success we are seeing in the market,” said Tarek Sherif , chairman and
NEW YORK --(BUSINESS WIRE)--Oct. 17, 2018-- Medidata (NASDAQ:MDSO) today announced that it will hold its Investor Day on October 24, 2018 in New York . The event will be webcast live from 8:30 a.m. to 10:30 a.m. and again at 1:30 p.m. to end at 3 p.m. ET at http://investor.mdsol.com .